Navigation Links
Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study
Date:2/4/2009

-Preliminary Data Show Seven of 17 Evaluable Patients Achieved an Objective Tumor Response by End of Four Treatment Cycles-

TUSTIN, Calif., Feb. 4 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today reported that its lead product candidate bavituximab achieved the primary efficacy endpoint in the first stage of its ongoing Phase II clinical trial in patients with non-small cell lung cancer (NSCLC). The open-label, Simon two-stage study is designed to evaluate the safety and efficacy of the combination of bavituximab with the chemotherapy drugs carboplatin and paclitaxel in NSCLC patients. Seventeen of the 21 patients enrolled in Stage A were deemed evaluable for tumor response by the end of four treatment cycles, with six patients achieving partial tumor responses and one patient achieving a complete tumor response, according to RECIST criteria. These preliminary results exceed the pre-specified benchmark criteria established for enrolling an additional 28 patients in Stage B of this trial, up to a total of 49 patients.

"We are very pleased with the promising early results from this pilot Phase II lung cancer trial and will now move forward to initiate the second stage of the study," said Steven W. King, president and CEO of Peregrine. "We are encouraged by the number of tumor responses seen at this early time point of approximately 12 weeks in patients with NSCLC, a leading cause of cancer deaths that responds poorly to current treatments. As these patients continue on treatment, we will be assessing them for further signs of anti-tumor activity, and we look forward to sharing more data from this study as patient treatment and follow-up progress."

The primary objective of the multi-center Phase II clinical trial in patients with previously untreated locally advanced or metastatic NS
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
2. Peregrine Pharmaceuticals Mourns Loss of Chairman Thomas A. Waltz
3. Peregrine Pharmaceuticals Enters Into a Loan Agreement for up to $10 Million
4. Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results
5. Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
6. Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008
7. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
8. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
9. Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
10. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
11. Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Utah , July 10, 2014 /PRNewswire-iReach/ ... annotation and interpretation, today announced an agreement ... (NGS) analytics for Lineagen,s NextStep Dx ... of neurodevelopmental and neurological disorders, currently offers ... microarray (CMA) testing service used by healthcare ...
(Date:7/10/2014)... THOUSAND OAKS, Calif., July 10, 2014   Ceres, ... biotechnology and seed company, announced today financial results for ... an update on its business. Ceres reported ... progress in product performance this growing season in Brazil, ... that affected the company,s sorghum evaluation areas for part ...
(Date:7/10/2014)... the fight against terrorism with the creation of a ... the use of light and special glass fibres. , ... Chemical , the researchers describe a novel optical fibre ... as 6.3 ppm (parts per million). It requires an ... explosives detection has involved looking for metals that encase ...
(Date:7/10/2014)... in the journal PNAS (Proceedings of the National ... day and sleep deprivation have a significant effect on ... at the best time of day to test for ... administering medicines effectively. , Researchers from the University of ... the links between sleep deprivation, body clock disruption and ...
Breaking Biology Technology:Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9Detecting trace amounts of explosives with light 2Time of day crucial to accurately test for diseases, new research finds 2
... Immucor, Inc. (Nasdaq:,BLUD), a global leader in providing automated instrument-reagent ... the fiscal year ending May 31, 2009., For fiscal ... $292 million to $300 million., -- ... to 71%., -- Net income is expected to be in ...
... DANBURY, Conn., June 4 Biodel Inc. (Nasdaq:,BIOD) today ... Corporate Development and Treasurer of Biodel, will present a,corporate ... on,Friday, June 6, 2008 at 1:40 p.m. Pacific Daylight ... San Francisco., Interested parties may access a link ...
... held in ... Georgia, ATLANTA, June 4 ... 17 -- 20, in,San Diego, Calif. Governor Perdue will deliver remarks on June ... of the fastest-growing industries in the nation, the,biosciences sector is a strategic priority ...
Cached Biology Technology:Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance 2Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance 3Georgia Showcases its Bioscience Leadership at 2008 Bio International Convention 2Georgia Showcases its Bioscience Leadership at 2008 Bio International Convention 3
(Date:7/10/2014)... open ocean as a microbial megacity, teeming with life ... water, hundreds of types of bacteria can be found. ... ocean microbes have their own daily cyclesnot unlike the ... up, commute, work, and eat at the same times., ... photoautotrophsbacteria that need solar energy to help them photosynthesize ...
(Date:7/10/2014)... if you are a big, bad sea scorpion. , ... waters for any prey in sight. The next, thanks ... you,re reduced to trolling for weaker, soft-bodied animals you ... of the giant pterygotid eurypterid, the largest arthropod that ... in the journal Biology Letters , dramatically re-interprets ...
(Date:7/10/2014)... JUPITER, FL, July 10, 2014 Amidst the astounding ... of synaptic connections in the brain, how do nerve ... connections to build? How do they coordinate these events ... scientists from the Florida campus of The Scripps Research ... processes, showing that a particular protein plays a far ...
Breaking Biology News(10 mins):New research finds ocean's most abundant organisms have clear daily cycles 2New research finds ocean's most abundant organisms have clear daily cycles 3Extinct sea scorpion gets a Yale eye exam, with surprising results 2Scripps Florida scientists shed new light on nerve cell growth 2
... FAHA, the Aram V. Chobanian Professor of Cardiovascular ... at Boston University School of Medicine (BUSM), has ... Distinguished Scientist. The AHA designated only five Distinguished ... Distinguished Scientist designation in 2003 to recognize science ...
... at Boston University School of Medicine (BUSM) have brought attention ... and their infants from consuming brown seaweed soup. Seaweed is ... there is no scientific data on the iodine content in ... Editor for the journal Thyroid and published online, ...
... What looks like a spongy ball wrapped in strands ... be key to unlocking better methods for catalysis, artificial ... University chemists who have created a platform to analyze ... photoluminescent materials. The microscopic particles assembled in ...
Cached Biology News:BUSM professor selected as American Heart Association Distinguished Scientist 2BUSM researchers urge awareness of dietary iodine intake in postpartum Korean-American women 2Supramolecules get time to shine 2Supramolecules get time to shine 3
... Salmonella genomes has allowed the development of ... pairs. The S. enterica Typhimurium (strain LT2) ... bp; 4,440 ORFs) and a plasmid, pSLT ... Sigma-Genosys have been designed to amplify all ...
... The Bio-Stack Twister II Microplate ... top automation solution for integrating BioTeks ... together with expandable microplate capacity, ultimate ... Whether you are adding capacity to ...
XPLAC (S-17)...
Request Info...
Biology Products: